219 related articles for article (PubMed ID: 33228610)
1. Metabolite biomarkers of type 2 diabetes mellitus and pre-diabetes: a systematic review and meta-analysis.
Long J; Yang Z; Wang L; Han Y; Peng C; Yan C; Yan D
BMC Endocr Disord; 2020 Nov; 20(1):174. PubMed ID: 33228610
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis.
Sun Y; Gao HY; Fan ZY; He Y; Yan YX
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31782507
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.
Guasch-Ferré M; Hruby A; Toledo E; Clish CB; Martínez-González MA; Salas-Salvadó J; Hu FB
Diabetes Care; 2016 May; 39(5):833-46. PubMed ID: 27208380
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus.
Zhao Z; Li X; Jian D; Hao P; Rao L; Li M
Acta Diabetol; 2017 Mar; 54(3):237-245. PubMed ID: 27878383
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Value of Whole Blood lncRNA ENST00000550337.1 for Pre-Diabetes and Type 2 Diabetes Mellitus.
Li X; Zhao Z; Gao C; Rao L; Hao P; Jian D; Li W; Tang H; Li M
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):377-383. PubMed ID: 28407663
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus.
Spiller S; Blüher M; Hoffmann R
Diabetes Obes Metab; 2018 Nov; 20(11):2661-2669. PubMed ID: 29943387
[TBL] [Abstract][Full Text] [Related]
8. Increased serum/plasma fibroblast growth factor 21 in type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang YS; Ye J; Cao YH; Zhang R; Liu Y; Zhang SW; Dai W; Zhang Q
Postgrad Med J; 2019 Mar; 95(1121):134-139. PubMed ID: 30918117
[TBL] [Abstract][Full Text] [Related]
9. CMPF: A Biomarker for Type 2 Diabetes Mellitus Progression?
Koppe L; Poitout V
Trends Endocrinol Metab; 2016 Jul; 27(7):439-440. PubMed ID: 27132217
[TBL] [Abstract][Full Text] [Related]
10. Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis.
Zaccardi F; Rocca B; Pitocco D; Tanese L; Rizzi A; Ghirlanda G
Diabetes Metab Res Rev; 2015 May; 31(4):402-10. PubMed ID: 25421610
[TBL] [Abstract][Full Text] [Related]
11. Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis.
Zhang C; Ding Z; Lv G; Li J; Zhou P; Zhang J
J Diabetes; 2016 Jan; 8(1):56-62. PubMed ID: 25494632
[TBL] [Abstract][Full Text] [Related]
12. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic approaches to dissect dysregulated metabolism in the progression of pre-diabetes to T2DM.
Ji W; Xie X; Bai G; He Y; Li L; Zhang L; Qiang D
Mol Omics; 2024 Jun; 20(5):333-347. PubMed ID: 38686662
[TBL] [Abstract][Full Text] [Related]
14. Metabolite changes in risk of type 2 diabetes mellitus in cohort studies: A systematic review and meta-analysis.
Park JE; Lim HR; Kim JW; Shin KH
Diabetes Res Clin Pract; 2018 Jun; 140():216-227. PubMed ID: 29626587
[TBL] [Abstract][Full Text] [Related]
15. Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.
Piccolo BD; Graham JL; Stanhope KL; Fiehn O; Havel PJ; Adams SH
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E958-69. PubMed ID: 27094034
[TBL] [Abstract][Full Text] [Related]
16. Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis.
Pan X; Kaminga AC; Wen SW; Liu A
Front Immunol; 2021; 12():622438. PubMed ID: 34054797
[TBL] [Abstract][Full Text] [Related]
17. Growth Differentiation Factor-15 as a Biomarker of Obese Pre-diabetes and Type 2 Diabetes Mellitus in Indian Subjects: A Case-control Study.
Roy D; Purohit P; Modi A; Khokhar M; Shukla RKG; Chaudhary R; Sankanagoudar S; Sharma P
Curr Diabetes Rev; 2022; 18(1):e010321189862. PubMed ID: 33397240
[TBL] [Abstract][Full Text] [Related]
18. NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus.
Del Coco L; Vergara D; De Matteis S; Mensà E; Sabbatinelli J; Prattichizzo F; Bonfigli AR; Storci G; Bravaccini S; Pirini F; Ragusa A; Casadei-Gardini A; Bonafè M; Maffia M; Fanizzi FP; Olivieri F; Giudetti AM
J Clin Med; 2019 May; 8(5):. PubMed ID: 31117294
[TBL] [Abstract][Full Text] [Related]
19. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study.
Jiménez-Lucena R; Camargo A; Alcalá-Diaz JF; Romero-Baldonado C; Luque RM; van Ommen B; Delgado-Lista J; Ordovás JM; Pérez-Martínez P; Rangel-Zúñiga OA; López-Miranda J
Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30598522
[TBL] [Abstract][Full Text] [Related]
20. Type 2 Diabetes Mellitus in Nepal from 2000 to 2020: A systematic review and meta-analysis.
Shrestha DB; Budhathoki P; Sedhai YR; Marahatta A; Lamichhane S; Nepal S; Adhikari A; Poudel A; Nepal S; Atreya A
F1000Res; 2021; 10():543. PubMed ID: 34621512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
